- Home
- BRTX vs OMEX Comparison
BRTX vs OMEX Comparison
Compare BRTX & OMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- OMEX
- Stock Information
- Founded
- BRTX 1997
- OMEX 1986
- Country
- BRTX United States
- OMEX United States
- Employees
- BRTX N/A
- OMEX N/A
- Industry
- BRTX Managed Health Care
- OMEX Marine Transportation
- Sector
- BRTX Health Care
- OMEX Consumer Discretionary
- Exchange
- BRTX Nasdaq
- OMEX Nasdaq
- Market Cap
- BRTX 11.2M
- OMEX 9.3M
- IPO Year
- BRTX N/A
- OMEX N/A
- Fundamental
- Price
- BRTX $1.85
- OMEX $0.40
- Analyst Decision
- BRTX Strong Buy
- OMEX
- Analyst Count
- BRTX 1
- OMEX 0
- Target Price
- BRTX $18.00
- OMEX N/A
- AVG Volume (30 Days)
- BRTX 48.0K
- OMEX 563.9K
- Earning Date
- BRTX 03-27-2025
- OMEX 05-19-2025
- Dividend Yield
- BRTX N/A
- OMEX N/A
- EPS Growth
- BRTX N/A
- OMEX N/A
- EPS
- BRTX N/A
- OMEX 0.07
- Revenue
- BRTX $401,000.00
- OMEX $768,677.00
- Revenue This Year
- BRTX $482.76
- OMEX N/A
- Revenue Next Year
- BRTX $212.24
- OMEX N/A
- P/E Ratio
- BRTX N/A
- OMEX $5.57
- Revenue Growth
- BRTX 175.03
- OMEX N/A
- 52 Week Low
- BRTX $1.03
- OMEX $0.30
- 52 Week High
- BRTX $2.55
- OMEX $5.57
- Technical
- Relative Strength Index (RSI)
- BRTX 53.36
- OMEX 40.31
- Support Level
- BRTX $1.72
- OMEX $0.37
- Resistance Level
- BRTX $1.85
- OMEX $0.58
- Average True Range (ATR)
- BRTX 0.13
- OMEX 0.05
- MACD
- BRTX 0.02
- OMEX 0.00
- Stochastic Oscillator
- BRTX 50.98
- OMEX 12.06
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodule (battery metals) projects. Its projects include ExO Phosphate project, CIC, Ocean Minerals, and LIHIR Gold project.